USDA licenses long-acting injectable for canine allergic dermatitisNovember 12, 2026 With a 75-day dosing interval, the monoclonal antibody (mAb) treatment helps reduce the number of clinic visits required for managing allergic dermatitis and lower the risk of missed doses.
Education Center - SponsoredReclaiming Lost Hours: How Digital Prescription Management Is Reshaping Veterinary Workflowsby • MWI Animal HealthAs administrative burdens grow, digital prescription management offers veterinary teams a path to greater efficiency, fewer errors, and more time for patient care.